An open-label, randomized, crossover study to estimate the formulation effect on the relative bioavailability of single dose oral SB-742510 in healthy subjects.

Trial Profile

An open-label, randomized, crossover study to estimate the formulation effect on the relative bioavailability of single dose oral SB-742510 in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2008

At a glance

  • Drugs SB 742510 (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 Apr 2008 Status changed from in progress to completed
    • 21 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top